Search - tctmd.com

Displaying 61 - 78 of 78

Sort: Relevancy | Date

Presentation TVT 2013

Can the Coronary Sinus Approach or Annuloplasty "Work" in FMR? A Surgical Perspective

Presenter: Michael Mack

June 14, 2013

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

$The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...$

Presentation TCT 2013

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

Presenter: Shmuel Banai, Marc Jolicoeur, Jean-Fran?ois Tanguay, Elazer Edelman, Stefan Verheye

January 31, 2013

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

Presentation TCT 2012

PCI In Anomalous Origin Of RCA From Left Coronary Sinus

Presenter: Jay Shah

October 22, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Daily News

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

L.A. McKeown

October 18, 2012

News Industry News

Miracor reports First-In-Man results using its PICSO® system to treat severe heart attack patients

July 05, 2012

Presentation TVT 2012

Critical Lessons from "Failed" Coronary Sinus Annuloplasty Programs

Presenter: Alec Vahanian

June 04, 2012

News Conference News ACC 2012

Early Cardiac CTA Improves Decision-Making in Suspected ACS

L.A. McKeown

March 27, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Industry News

Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease

February 19, 2012

Presentation TCT 2012

Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO®): Results From the First-In-Man Prepare PICSO® Pilot Study.

Presenter: Tim P. van de Hoef, Froukje Nolte, Ronak Delewi, M. Cristina Rolandi, Jos? P. Henriques, Jos A. Spaan, Maria Siebes, Joanna J. Wykrzykowska, Jan J. Piek

January 03, 2012

News Industry News

Miracor to report successful clinical study results of its PICSO® system designed to improve myocardial perfusion following primary PCI

November 04, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Industry News

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

March 03, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

Advertisement

Can the Coronary Sinus Approach or Annuloplasty "Work" in FMR? A Surgical Perspective

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

PCI In Anomalous Origin Of RCA From Left Coronary Sinus

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

Miracor reports First-In-Man results using its PICSO® system to treat severe heart attack patients

Critical Lessons from "Failed" Coronary Sinus Annuloplasty Programs

Early Cardiac CTA Improves Decision-Making in Suspected ACS

Live Case Procedures Just as Safe as in Daily Practice

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease

Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO®): Results From the First-In-Man Prepare PICSO® Pilot Study.

Miracor to report successful clinical study results of its PICSO® system designed to improve myocardial perfusion following primary PCI

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content